Hemophilia C: Difference between revisions

Jump to navigation Jump to search
Apalmer (talk | contribs)
No edit summary
 
Lakshmi Gopalakrishnan (talk | contribs)
No edit summary
Line 9: Line 9:
   OMIM          = 264900 |
   OMIM          = 264900 |
   MedlinePlus    = |
   MedlinePlus    = |
  eMedicineSubj  = ped |
  eMedicineTopic = 964 |
  eMedicine_mult = {{eMedicine2|med|3515}} |
   MeshID        = D005173 |
   MeshID        = D005173 |
}}
}}
Line 20: Line 17:


==Overview==
==Overview==
'''Hemophilia C''' is a mild form of [[haemophilia]] affecting both sexes. However, it predominantly occurs in Jews of Ashkenazi descent. It is the fourth most common [[coagulation]] disorder after [[von Willebrand's disease]] and [[haemophilia]] [[Haemophilia A|A]] and [[Haemophilia B|B]].<ref>http://www.gpnotebook.co.uk/cache/-885719013.htm</ref> In the USA it is thought to affect 1 in 100,000 of the adult population, making it 10% less common than haemophillia A. <ref>http://www.emedicine.com/ped/topic964.htm</ref>
'''Hemophilia C''' is a mild form of [[haemophilia]] affecting both sexes. However, it predominantly occurs in Jews of Ashkenazi descent. It is the fourth most common [[coagulation]] disorder after [[von Willebrand's disease]] and [[haemophilia]] [[Haemophilia A|A]] and [[Haemophilia B|B]].


It is caused by a deficiency of [[coagulation]] [[factor XI]] and is distinguished from haemophilia A and B by the fact it does not lead to bleeding into the joints. Furthermore, it has [[autosomal]] recessive inheritance, since the gene for factor XI is located on chromosome 4 (close to the prekallikrein gene). Many mutations exist, and the bleeding risk is not always influenced by the severity of the deficiency. Treatment is usually not necessary, except in relation to [[Surgery|operation]]s, leading to many of those having the condition not being aware of it. In these cases, [[fresh frozen plasma]] or recombinant factor XI may be used, but only if necessary. The afflicted may often suffer nosebleeds, and females can experience heavy [[menstrual bleeding]].<ref>http://www.haemophilia.org.uk/index.php?content_id=91&parent=278</ref> Hemophaelia C was first discovered in a young Ashkenazic Jewish American in the 1950s.
It is caused by a deficiency of [[coagulation]] [[factor XI]] and is distinguished from haemophilia A and B by the fact it does not lead to bleeding into the joints. Furthermore, it has [[autosomal]] recessive inheritance, since the gene for factor XI is located on chromosome 4 (close to the prekallikrein gene). Many mutations exist, and the bleeding risk is not always influenced by the severity of the deficiency. Treatment is usually not necessary, except in relation to [[Surgery|operation]]s, leading to many of those having the condition not being aware of it. In these cases, [[fresh frozen plasma]] or recombinant factor XI may be used, but only if necessary. The afflicted may often suffer nosebleeds, and females can experience heavy [[menstrual bleeding]]. Hemophaelia C was first discovered in a young Ashkenazic Jewish American in the 1950s.


==Symptoms==
==Symptoms==
The symptoms of Haemophilia C are the same as those for other forms of Haemophilia, mainly:<ref>http://www.doctorndtv.com/topics/searchdetailtopics.asp?id=528</ref>
The symptoms of Haemophilia C are the same as those for other forms of Haemophilia, mainly:
*Prolonged bleeding from injuries.
*Prolonged bleeding from injuries.
*Frequent or heavy nosebleeds.
*Frequent or heavy nosebleeds.
Line 34: Line 31:
*[[Haemophilia A]]
*[[Haemophilia A]]
*[[Haemophilia B]]
*[[Haemophilia B]]
==References==
{{FootnotesSmall|resize=92%}}


{{Hematology}}
{{Hematology}}
Line 44: Line 37:
[[pt:Hemofilia C]]
[[pt:Hemofilia C]]


[[Category:Disease state]]
[[Category:Genetic disorders]]
[[Category:Genetic disorders]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Coagulation system]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 15:48, 29 July 2011

Hemophilia C
ICD-10 D68.1
ICD-9 286.2
OMIM 264900
DiseasesDB 29376
MeSH D005173

WikiDoc Resources for Hemophilia C

Articles

Most recent articles on Hemophilia C

Most cited articles on Hemophilia C

Review articles on Hemophilia C

Articles on Hemophilia C in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hemophilia C

Images of Hemophilia C

Photos of Hemophilia C

Podcasts & MP3s on Hemophilia C

Videos on Hemophilia C

Evidence Based Medicine

Cochrane Collaboration on Hemophilia C

Bandolier on Hemophilia C

TRIP on Hemophilia C

Clinical Trials

Ongoing Trials on Hemophilia C at Clinical Trials.gov

Trial results on Hemophilia C

Clinical Trials on Hemophilia C at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hemophilia C

NICE Guidance on Hemophilia C

NHS PRODIGY Guidance

FDA on Hemophilia C

CDC on Hemophilia C

Books

Books on Hemophilia C

News

Hemophilia C in the news

Be alerted to news on Hemophilia C

News trends on Hemophilia C

Commentary

Blogs on Hemophilia C

Definitions

Definitions of Hemophilia C

Patient Resources / Community

Patient resources on Hemophilia C

Discussion groups on Hemophilia C

Patient Handouts on Hemophilia C

Directions to Hospitals Treating Hemophilia C

Risk calculators and risk factors for Hemophilia C

Healthcare Provider Resources

Symptoms of Hemophilia C

Causes & Risk Factors for Hemophilia C

Diagnostic studies for Hemophilia C

Treatment of Hemophilia C

Continuing Medical Education (CME)

CME Programs on Hemophilia C

International

Hemophilia C en Espanol

Hemophilia C en Francais

Business

Hemophilia C in the Marketplace

Patents on Hemophilia C

Experimental / Informatics

List of terms related to Hemophilia C

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Hemophilia C is a mild form of haemophilia affecting both sexes. However, it predominantly occurs in Jews of Ashkenazi descent. It is the fourth most common coagulation disorder after von Willebrand's disease and haemophilia A and B.

It is caused by a deficiency of coagulation factor XI and is distinguished from haemophilia A and B by the fact it does not lead to bleeding into the joints. Furthermore, it has autosomal recessive inheritance, since the gene for factor XI is located on chromosome 4 (close to the prekallikrein gene). Many mutations exist, and the bleeding risk is not always influenced by the severity of the deficiency. Treatment is usually not necessary, except in relation to operations, leading to many of those having the condition not being aware of it. In these cases, fresh frozen plasma or recombinant factor XI may be used, but only if necessary. The afflicted may often suffer nosebleeds, and females can experience heavy menstrual bleeding. Hemophaelia C was first discovered in a young Ashkenazic Jewish American in the 1950s.

Symptoms

The symptoms of Haemophilia C are the same as those for other forms of Haemophilia, mainly:

  • Prolonged bleeding from injuries.
  • Frequent or heavy nosebleeds.
  • Traces of blood in the urine.

See also

Template:Hematology Template:SIB


Template:WikiDoc Sources